Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPFZ.L Regulatory News (PFZ)

  • There is currently no data for PFZ

Form 8.3 - Pfizer Inc.

2 Nov 2015 11:55

RNS Number : 1189E
Capital Group Companies Inc
02 November 2015
 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

 

1. KEY INFORMATION

 

Name of person dealing (Note 1)

The Capital Group Companies, Inc.

Company dealt in

Pfizer Inc

Class of relevant security to which the dealings being disclosed relate (Note 2)

USD ordinary shares

(ISIN: US7170811035)

Date of dealing

30 October 2015

 

2. INTERESTS AND SHORT POSITIONS

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

166,508,545 (2.70%)

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

166,508,545* (2.70%)

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 

Class of relevant security:

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

 

 

1. DEALINGS (Note 4)

 

(a) Purchases and sales

 

 

Purchase/sale

 

Number of relevant securities

 

Price per unit (Note 5)

Sale

13,900

USD 34.6342

 

 

 

(b) Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

(c) Options transactions in respect of existing relevant securities

 

 

(i) Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

(ii) Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

2. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached? (Note 9) NO

 

Date of disclosure

Contact name

Vivien Tan

Telephone number

+213.615.0469

If a connected EFM, name of offeree/offeror with which connected

n/a

If a connected EFM, state nature of connection (Note 10)

n/a

 

*104 shares due to transfer in.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ISEEAFEFDFXSFEF
Date   Source Headline
17th Nov 20153:32 pmRNSForm 8.3 - Pfizer Inc Amendment
17th Nov 20153:32 pmRNSForm 8.3 - Pfizer Inc
17th Nov 20153:21 pmRNSForm 8.3 - Pfizer Inc
17th Nov 20153:16 pmRNSForm 8.3 - [PFIZER INC]
17th Nov 20153:14 pmRNSForm 8.3 - Allergan plc
17th Nov 20152:56 pmBUSForm 8.3 - Pfizer Inc.
17th Nov 20152:45 pmRNSForm 8.3 - ALLERGAN PLC
17th Nov 20152:36 pmRNSForm 8.3 - PFIZER INC
17th Nov 20152:27 pmRNSForm 8.3 - Pfizer Inc.
17th Nov 20152:26 pmRNSRule 38.5 - Replacement Pfizer INC
17th Nov 20152:24 pmRNSForm 8.3 - Pfizer Inc
17th Nov 20152:23 pmRNSForm 8.3 - Allergan plc
17th Nov 20152:07 pmRNSForm 8.3 - Allergan Plc
17th Nov 201512:10 pmRNSForm 38.5a
17th Nov 201512:09 pmRNSForm 38.5b
17th Nov 201512:07 pmRNSForm 38.5b
17th Nov 201512:03 pmRNSForm 8.1 - [Pfizer Inc]
17th Nov 201511:55 amRNSForm 8.3 - Pfizer Inc.
17th Nov 201511:43 amRNSForm 38.5(b) - Pfizer Inc
17th Nov 201511:16 amRNSForm 38.5(a) - Pfizer Inc
17th Nov 201510:30 amRNSRule 38.5 - Pfizer INC
17th Nov 201510:29 amRNSRule 38.5 - Pfizer INC
17th Nov 201510:28 amRNSRule 38.5 - Pfizer INC
17th Nov 20157:00 amRNSForm 8.3 - Pfizer, Inc Replacement non material
16th Nov 20154:05 pmRNSForm 8.3 - Allergan PLC
16th Nov 20153:52 pmRNSForm 8.3 - PFIZER INC
16th Nov 20153:49 pmRNSForm 8.3 - PFIZER INC.
16th Nov 20153:34 pmRNSForm 8.3 - Pfizer Inc
16th Nov 20153:27 pmRNSForm 8.3 - Allergan plc
16th Nov 20153:25 pmRNSForm 8.3 - Allergan plc
16th Nov 20153:13 pmRNSForm 8.3 - Pfizer Inc
16th Nov 20153:12 pmRNSForm 8.3 - Pfizer Inc Amendment
16th Nov 20153:05 pmRNSForm 8.3 - [PFIZER INC]
16th Nov 20153:03 pmRNSForm 8.3 - Pfizer Inc
16th Nov 20153:02 pmBUSForm 8.3 - Pfizer Inc.
16th Nov 20152:47 pmRNSForm 8.3 - Pfizer, Inc.
16th Nov 20152:41 pmRNSForm 8.3 - Pfizer Inc
16th Nov 20152:28 pmRNSForm 8.3 - Allergan Plc
16th Nov 201512:03 pmRNSForm 38.5b
16th Nov 201512:03 pmRNSForm 8.1- [Pfizer]
16th Nov 201512:03 pmRNSForm 38.5a
16th Nov 201512:01 pmRNSForm 38.5b
16th Nov 201511:55 amRNSForm 8.3 - Pfizer Inc
16th Nov 201511:50 amRNSForm 38.5b
16th Nov 201511:49 amRNSForm 38.5(b) - Pfizer Inc
16th Nov 201511:32 amRNSForm 8.1a - Pfizer Inc
16th Nov 201511:10 amRNSRule 38.5 - Pfizer INC
16th Nov 201511:09 amRNSRule 38.5 - Pfizer INC
16th Nov 201511:09 amRNSRule 38.5 - Pfizer INC
13th Nov 20155:16 pmRNSForm 38.5(b) - Pfizer Inc. - Amendment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.